Quick Answer
Exousia Bio, Inc. reported Gross Profit of -$3.5 thousand for fiscal year 2025.
Exousia Bio, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | -$3.5K | -291.0% |
| 2024 | $1.8K | — |
| 2023 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$62.1K | — | — |
| August 31, 2025 | $0.00 | -100.0% | — |
| February 28, 2025 | $0.00 | -100.0% | — |
| November 30, 2024 | $0.00 | -100.0% | -100.0% |
| August 31, 2024 | $3.8K | — | -3.2% |
| February 29, 2024 | $3.9K | — | +0.0% |
| November 30, 2023 | $3.9K | — | — |
| August 31, 2023 | $0.00 | — | — |
- Exousia Bio, Inc. showed a decrease of -291.0% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from Exousia Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: